HAYWARD, CA -- (MARKET WIRE) -- March 29, 2007 -- Aradigm Corporation (OTCBB: ARDM) today announced financial results for the fourth quarter and the year ended December 31, 2006. The company reported revenues for the three months ended December 31, 2006 of $0.8 million compared to $0.9 million for the same period in 2005. Revenues for the twelve months ended December 31, 2006 were $4.8 million compared with $10.5 million for the same period in 2005. Revenues were from partnered development programs. The decrease in revenue in 2006 compared to 2005 is due primarily to decreases in project development revenue from Novo Nordisk, as a consequence of our amending our collaborative agreement with Novo Nordisk, effective January 26, 2005.
